GSK3B and glioblastoma: The inhibition of GSK-3β has been shown to complement the function of CD28 as a costimulatory molecule in the proliferation of human T cells [85] and has been found to prolong the survival and enhance the anti-tumor cytotoxicity of chimeric antigen receptor T cells in the setting of a glioblastoma model [86,87].